The U.S. Food and Drug Administration announced it will complete its phase-out of all inhaler medical products containing chlorofluorocarbons (CFCs) by Dec. 31, 2013. This complies with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback